Summary
The effects of various pretreatment schedules with L-thyroxine (T4) on endogenous brain concentrations of catecholamines (CA) and 5-hydroxy-tryptamine (5-HT) as well as their respective synthesis ratesin vivo and the sensitivity of CA-and 5-HT receptors, respectively, were investigated. None of the T4 pretreatments had any significant effect on the brain concentrations of noradrenaline, dopamine or 5-HT. The CA-and 5-HT synthesis rates were significantly increased by 2, 3, or 4 s.c. injections but not by 1 injection of T4 (1 mg/kg, 12 hours intervals, 6 hours after the last T4 injection), as indicated by increased accumulations of DOPA and 5-hydroxytryptophan (5-HTP), respectively, during 30 min following complete inhibition of their decarboxylation. The CA receptor sensitivity seemed to be increased following 3 or 4 injections of T4, but not after 1 or 2 injections, as indicated by a significantly increased response (i.e. locomotor stimulation) to a dopamine receptor agonist (ET 495, 20 mg/kg i.p.)plus a NA receptor agonist (clonidine, 2 mg/kg i.p.) in mice made deficient in CA by pretreatment with reserpine (10 mg/kg i.p. 6 hours) and a tyrosine hydroxylase inhibitor (DL-α-methyl-p-tyrosine methylester, 250 mg/ kg i.p., 1 hour). In contrast, the sensitivity of central 5-HT receptors seemed not to be altered by 4 injections of T4, as indicated by an unchanged response (i.e. locomotor stimulation) to DL-5-HTP (75 mg/kg i.p.) following inhibition of peripheral but not central decarboxylase. Thus, the presynaptic event, the increased CA synthesis rate, preceded in onset the probably postsynaptic event, the increased CA receptor sensitivity, suggesting different mechanisms to be involved in the two phenomena. The increased synthesis rate of both CA and 5-HT may reflect a generally increased metabolism in the hyperthyroid state. Since the CA-but not the 5-HT receptors in our tests showed increased sensitivity, the former effect may be a specific effect of T4,i.e., not reflecting a generally increased receptor sensitivity.
Similar content being viewed by others
References
Andén, N.-E., H. Corrodi, K. Fuxe, B. Hökfelt, T. Hökfelt, C. Rydin, andT. Svensson: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci.9 (1), 513–523 (1970).
Andén, N.-E., U. Strömbom, andT. H. Svensson: Dopamine and noradrenaline receptor Stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.)29, 289–298 (1973).
Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Brit. J. Pharm.48, 699–714 (1973).
Atack, C. V., andM. Lindqvist: Conjoint native and orthophthaldialdehyde-condensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.279, 267–284 (1973).
Atack, C. V., andT. Magnusson: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmac.22, 625 to 627 (1970).
Bédard, P., A. Carlsson, andM. Lindqvist: Effect of transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol.272, 1–15 (1972).
Bertler, Å., A. Carlsson, andE. Rosengren: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand.44, 273–292 (1958).
Carlsson, A.: Effect of drugs on amine uptake mechanisms in the brain. Bayer-Symposium II, pp. 223–233. Berlin-Heidelberg-New York: Springer. 1970.
Carlsson, A., J. N. Davis, W. Kehr, M. Lindqvist, andC. V. Atack: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brainin vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol.275, 153–168 (1972).
Emlen, W., D. S. Segal, andA. J. Mandell: Thyroid state: effects on pre-and post-synaptic noradrenergic mechanisms. Science175, 79–82 (1972).
Engström, G., T. H. Svensson, andB. Waldeck: Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. Brain Res.77, 471–483 (1974).
Kehr, W., A. Carlsson, andM. Lindqvist: A method for the determination of 3, 4-dihydroxyphenylalanine (Dopa) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 273–280 (1972).
Klawans, H. L., Jr., Ch. Goetz, andW. J. Weiner: Dopamine receptor site sensitivity in hyperthyroid guinea pigs: A possible model of hyperthyroid chorea. J. Neural Transm.34, 187–193 (1973).
Landsberg, L., andJ. Axelrod: Reduced accumulation of3H-norepinephrine in the rat heart following hypophysectomy. Endocrinology82, 175 to 178 (1968).
Lindqvist, M.: Quantitative estimation of 5-hydroxy-3-indole acetic acid and 5-hydroxytryptophan in the brain following isolation by means of a strong cation exchange column. Acta pharmacol. et toxicol.29, 303–313 (1971).
Modigb, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.)23, 48–54 (1972).
Modigh, K.: Effects of chlorimipramine and protriptyline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice. J. Neural Transm.34, 101–109 (1973).
Prange, A. J., Jr., J. L. Meek, andM. A. Lipton: Catecholamines: Diminished rate of synthesis in rat brain and heart after thyroxine pretreatment. Life Sci.9, 901–907 (1970).
Prange, A. J., Jr., I. C. Wilson, A. M. Rabon, andM. A. Lipton: Enhancement of imipramine antidepressant activity by thyroid hormone. Amer. J. Psychiat.126, 457–469 (1969).
Walkes, T. P., andS. Udenfriend: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. clin. Med.50, 733–736 (1957).
Wheatley, D.: Potentiation of amitriptyline by thyroid hormone. Arch. Gen. Psychiatry26, 229–245 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Engström, G., Strömbom, U., Svensson, T.H. et al. Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine. J. Neural Transmission 37, 1–10 (1975). https://doi.org/10.1007/BF01249761
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249761